サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1472135

脊椎生物製剤の世界市場規模調査＆予測、製品別、最終用途別、地域別分析、2023年～2030年

Global Spine Biologics Market Size Study & Forecast, by Product (Spinal Allografts, Bone Graft Substitutes, Cell-base Matrix), By End-use (Hospitals, Ambulatory Surgical Centers), and Regional Analysis, 2023-2030

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脊椎生物製剤の世界市場規模調査＆予測、製品別、最終用途別、地域別分析、2023年～2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脊椎生物製剤の世界市場は、2022年に約29億米ドルと評価され、予測期間2023-2030年には5.08%以上の健全な成長率で成長すると予測されています。

脊椎生物製剤は、脊椎関連疾患の治療、治癒促進、組織再生、安定化に使用される生物学的材料です。骨移植片、骨形態形成タンパク質（BMP）、多血小板血漿（PRP）、間葉系幹細胞（MSC）などが含まれます。これらの材料は、骨の成長、組織の修復、再生を促すことで、治癒を促進し、合併症を減らし、脊椎手術の結果を改善します。脊椎生物製剤は、外傷、腫瘍、変性椎間板症、脊髄損傷などの病態に対処する脊椎固定手術において重要な役割を果たしています。脊椎生物製剤市場の成長は、脊椎疾患の有病率の増加、それに伴う治療率の上昇、最小限の術後時間や迅速な回復を含む生物学的製剤の利点に関する意識の高まりなどの要因によって牽引されています。

これとともに、脊椎生物製剤は脊椎固定術の様々な段階において骨の成長を促進するため、脊椎固定術の増加とともにその使用が増加しています。高齢者人口の増加は生物製剤需要の主要な促進要因であり、脊柱管狭窄症のような脊椎疾患は50歳以上の間で流行しています。加齢は脊椎の構造的変化を引き起こし、脊椎障害のリスクを高める。Journal of Spine Surgery（JSS）によると、脊柱の変形は加齢とともに蔓延し、高齢者人口の約30%から68%が罹患しています。また、経済社会省によると、2019年の世界の65歳以上の人口は合計7億300万人。また、高齢者の数は2050年までに15億人に増加すると予想されています。加齢に関連する疾患だけでなく、脊柱側弯症、後弯症、椎間板変性症などの脊椎疾患の有病率も上昇しています。その結果、高齢者における脊柱変形リスクの増加は、脊椎固定手術が世界的に増加するにつれて、脊椎生物製剤の需要を刺激すると予想されます。このように、高齢者人口の増加が推定期間中の脊椎生物製剤市場の成長を促進しています。さらに、骨移植手技の進歩の増加や低侵襲手技への傾斜の高まりは、予測期間中に様々な有利な機会を提示します。しかし、償還の問題、高い骨移植費用、倫理的な懸念が、2023-2030年の予測期間を通じて市場成長の妨げとなっています。

脊椎生物製剤の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、低侵襲手術への傾斜の高まりと、椎間板関連問題、脊柱管狭窄症、脊椎すべり症などの脊椎疾患の発生率の増加により、2022年の市場を独占しました。さらに、Orthofix Holdings, Inc.、Stryker、NuVasive, Inc.のような主要な業界プレーヤーが米国中に存在することが、地域の成長を促進すると予想されます。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されています。対象患者数の増加と、生物学的製剤の利点に関する患者や外科医の意識の高まりが、同地域全体の市場需要を大きく押し上げています。また、ヘルスケアインフラの開拓、医療支出の増加、脊椎損傷の発生率の急増が、この地域の市場成長に寄与しています。これとともに、座りがちなライフスタイルや行動パターンの変化が肥満の蔓延を招き、2023～2030年の予測期間における市場成長をさらに促進しています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 脊椎生物製剤の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 脊椎生物製剤の世界市場力学

  • 脊椎生物製剤市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 老人人口の増加
      • 脊椎疾患の有病率の増加
    • 市場の課題
      • 償還の問題
      • 骨移植手術の高コスト
    • 市場機会
      • 骨移植手技の進歩の増加
      • 低侵襲治療への志向の高まり

第4章 世界の脊椎生物製剤市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 脊椎生物製剤の世界市場：製品別

  • 市場スナップショット
  • 脊椎生物製剤の世界市場：製品別、実績 - ポテンシャル分析
  • 脊椎生物製剤の世界市場、製品別推定・予測：2020年～2030年
  • 脊椎生物製剤市場、サブセグメント別分析
    • 脊椎移植片
    • 骨移植代替物
    • 細胞ベースマトリックス

第6章 脊椎生物製剤の世界市場：最終用途別

  • 市場スナップショット
  • 脊椎生物製剤の世界市場：最終用途別、実績 - ポテンシャル分析
  • 脊椎生物製剤の世界市場、最終用途別推定・予測、2020年～2030年
  • 脊椎生物製剤の世界市場、サブセグメント別分析
    • 病院
    • 外来手術センター

第7章 脊椎生物製剤の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 脊椎生物製剤の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020年～2030年
      • 最終用途の推定・予測、2020年～2030年
    • カナダ
  • 欧州の脊椎生物製剤市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の脊椎生物製剤市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの脊椎生物製剤市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Stryker
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • NuVasive, Inc.
    • Orthofix
    • DePuy Synthes（Johnson & Johnson）
    • Exactech, Inc.
    • Zimmer Biomet
    • Arthrex, Inc.
    • Medtronic
    • Organogenesis Inc.
    • Kuros Biosciences.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Spine Biologics Market, report scope
  • TABLE 2.Global Spine Biologics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Spine Biologics Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4.Global Spine Biologics Market estimates & forecasts by End-use 2020-2030 (USD Billion)
  • TABLE 5.Global Spine Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6.Global Spine Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Spine Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Spine Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Spine Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Spine Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Spine Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Spine Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Spine Biologics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Spine Biologics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.U.S. Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17.U.S. Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.Canada Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19.Canada Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20.Canada Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.UK Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22.UK Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23.UK Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.Germany Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25.Germany Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26.Germany Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.France Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28.France Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29.France Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.Italy Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31.Italy Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32.Italy Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Spain Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34.Spain Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35.Spain Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.RoE Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37.RoE Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38.RoE Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.China Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40.China Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41.China Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.India Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43.India Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44.India Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.Japan Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46.Japan Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47.Japan Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.South Korea Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49.South Korea Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50.South Korea Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.Australia Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52.Australia Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53.Australia Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.RoAPAC Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.Brazil Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58.Brazil Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59.Brazil Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Mexico Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61.Mexico Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62.Mexico Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.RoLA Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64.RoLA Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65.RoLA Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.Saudi Arabia Spine Biologics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67.South Africa Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68.RoMEA Spine Biologics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.List of secondary sources, used in the study of global Spine Biologics Market
  • TABLE 70.List of primary sources, used in the study of global Spine Biologics Market
  • TABLE 71.Years considered for the study
  • TABLE 72.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Spine Biologics Market, research methodology
  • FIG 2.Global Spine Biologics Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Spine Biologics Market, key trends 2022
  • FIG 5.Global Spine Biologics Market, growth prospects 2023-2030
  • FIG 6.Global Spine Biologics Market, porters 5 force model
  • FIG 7.Global Spine Biologics Market, pest analysis
  • FIG 8.Global Spine Biologics Market, value chain analysis
  • FIG 9.Global Spine Biologics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Spine Biologics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Spine Biologics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Spine Biologics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Spine Biologics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Spine Biologics Market, regional snapshot 2020 & 2030
  • FIG 15.North America Spine Biologics Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Spine Biologics Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Spine Biologics Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Spine Biologics Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Spine Biologics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Spine Biologics Market is valued at approximately USD 2.90 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.08% over the forecast period 2023-2030. Spine biologics are biological materials used in treating spine-related conditions, promoting healing, tissue regeneration, or stabilization. They include bone grafts, bone morphogenetic proteins (BMPs), platelet-rich plasma (PRP), and mesenchymal stem cells (MSCs). These materials enhance healing, reduce complications, and improve outcomes in spinal surgeries by stimulating bone growth, tissue repair, and regeneration. Spine biologics play a crucial role in spine fusion surgery, addressing conditions like trauma, tumours, degenerative disc disease, and spinal cord injuries. The spinal biologics market growth is being driven by factors such as the increasing prevalence of spine disorders, subsequent increase in treatment rates, and the growing awareness regarding the benefits of biologics, including minimal postoperative time and faster recovery.

Along with this, spine biologics facilitate bone growth in various stages of spine fusion procedures, prompting their increased use with rising spinal fusion surgeries. The growing elderly population is a key driver for biologics demand, with spinal disorders like spinal stenosis prevalent among individuals over 50. Ageing induces structural spine changes, intensifying the risk of spinal impairments. The Journal of Spine Surgery (JSS) stated that Spinal deformities become more prevalent with age, affecting approximately 30% to 68% of the elderly population. Also, according to the Department of Economic and Social Affairs, in 2019, the world's population of people aged 65 and up totalled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. In addition to age-related conditions, the prevalence of other spine disorders, such as scoliosis, kyphosis, and intervertebral disc degeneration, is also rising. Consequently, the increase in the risk of spinal deformities among older individuals is expected to stimulate the demand for spine biologics as spinal fusion surgeries increase globally. Thus, the increase in the geriatric population is propelling the growth of the Spine Biologics Market during the estimated period. Moreover, the increase in advancements in bone grafting procedures, as well as the rising inclination towards minimally invasive procedures present various lucrative opportunities over the forecast years. However, reimbursement issues, high bone graft costs, and ethical concerns are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Spine Biologics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising inclination towards minimally invasive surgeries, and an increasing incidence of spine disorders such as disc-related issues, spinal stenosis, and spondylolisthesis. As per an article by the American Medical Association in May 2022, lumbar spinal stenosis is a prevalent issue, impacting approximately 11% of older adults in the U.S. Additionally, the presence of key industry players like Orthofix Holdings, Inc., Stryker, and NuVasive, Inc. throughout the U.S. is anticipated to bolster regional growth. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in the target patient population and growing awareness among patients and surgeons regarding the benefits of biologics are significantly propelling the market demand across the region. Also, the rise in the development of healthcare infrastructure, increasing healthcare spending, and a surge in the incidence of spine injuries are contributing to the region's market growth. Along with this, sedentary lifestyles and shifting behavioural patterns have led to an increased prevalence of obesity, further propelling market growth in the forecast period of 2023-2030.

Major market players included in this report are:

  • Stryker
  • NuVasive, Inc.
  • Orthofix
  • DePuy Synthes (Johnson & Johnson)
  • Exactech, Inc.
  • Zimmer Biomet
  • Arthrex, Inc.
  • Medtronic
  • Organogenesis Inc.
  • Kuros Biosciences.

Recent Developments in the Market:

  • In October 2023, Orthofix Medical Inc., a leading supplier of spine and orthopaedic solutions, unveiled the full commercial launch and 510k clearance of OsteoCove, an advanced bioactive synthetic graft designed for orthopaedic and spine procedures. OsteoCove is offered in strip and putty configurations to meet varied surgical needs.
  • In July 2023, Cerapedics Inc., a prominent bone graft provider, expanded its headquarters within the Denver metro area. This strategic expansion aims to bolster the company's diverse product portfolio, encompassing i-FACTOR bone grafts tailored for cervical spinal fusion procedures.
  • In April 2023, PUR Biologics, a subsidiary of HippoFi, Inc., launched PURcore, a bioactive moldable synthetic designed specifically for spinal surgeries.

Global Spine Biologics Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, End-use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Spinal Allografts
  • Bone Graft Substitutes
  • Cell-base Matrix

By End-use:

  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Spine Biologics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Spine Biologics Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3.Spine Biologics Market, by End-use, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Spine Biologics Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Spine Biologics Market Dynamics

  • 3.1.Spine Biologics Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increase in geriatric population
      • 3.1.1.2.Rising prevalence of spine disorders
    • 3.1.2.Market Challenges
      • 3.1.2.1.Reimbursement issues
      • 3.1.2.2.High cost of bone graft procedures
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Increase in advancements in bone grafting procedures
      • 3.1.3.2.Rising inclination towards minimally invasive procedures

Chapter 4.Global Spine Biologics Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Spine Biologics Market, by Product

  • 5.1.Market Snapshot
  • 5.2.Global Spine Biologics Market by Product, Performance - Potential Analysis
  • 5.3.Global Spine Biologics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4.Spine Biologics Market, Sub Segment Analysis
    • 5.4.1.Spinal Allografts
    • 5.4.2.Bone Graft Substitutes
    • 5.4.3.Cell-base Matrix

Chapter 6.Global Spine Biologics Market, by End-use

  • 6.1.Market Snapshot
  • 6.2.Global Spine Biologics Market by End-use, Performance - Potential Analysis
  • 6.3.Global Spine Biologics Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
  • 6.4.Spine Biologics Market, Sub Segment Analysis
    • 6.4.1.Hospitals
    • 6.4.2.Ambulatory Surgical Centers

Chapter 7.Global Spine Biologics Market, Regional Analysis

  • 7.1.Top Leading Countries
  • 7.2.Top Emerging Countries
  • 7.3.Spine Biologics Market, Regional Market Snapshot
  • 7.4.North America Spine Biologics Market
    • 7.4.1.U.S. Spine Biologics Market
      • 7.4.1.1.Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2.End-use breakdown estimates & forecasts, 2020-2030
    • 7.4.2.Canada Spine Biologics Market
  • 7.5.Europe Spine Biologics Market Snapshot
    • 7.5.1.U.K. Spine Biologics Market
    • 7.5.2.Germany Spine Biologics Market
    • 7.5.3.France Spine Biologics Market
    • 7.5.4.Spain Spine Biologics Market
    • 7.5.5.Italy Spine Biologics Market
    • 7.5.6.Rest of Europe Spine Biologics Market
  • 7.6.Asia-Pacific Spine Biologics Market Snapshot
    • 7.6.1.China Spine Biologics Market
    • 7.6.2.India Spine Biologics Market
    • 7.6.3.Japan Spine Biologics Market
    • 7.6.4.Australia Spine Biologics Market
    • 7.6.5.South Korea Spine Biologics Market
    • 7.6.6.Rest of Asia Pacific Spine Biologics Market
  • 7.7.Latin America Spine Biologics Market Snapshot
    • 7.7.1.Brazil Spine Biologics Market
    • 7.7.2.Mexico Spine Biologics Market
  • 7.8.Middle East & Africa Spine Biologics Market
    • 7.8.1.Saudi Arabia Spine Biologics Market
    • 7.8.2.South Africa Spine Biologics Market
    • 7.8.3.Rest of Middle East & Africa Spine Biologics Market

Chapter 8.Competitive Intelligence

  • 8.1.Key Company SWOT Analysis
  • 8.2.Top Market Strategies
  • 8.3.Company Profiles
    • 8.3.1.Stryker
      • 8.3.1.1.Key Information
      • 8.3.1.2.Overview
      • 8.3.1.3.Financial (Subject to Data Availability)
      • 8.3.1.4.Product Summary
      • 8.3.1.5.Recent Developments
    • 8.3.2.NuVasive, Inc.
    • 8.3.3.Orthofix
    • 8.3.4.DePuy Synthes (Johnson & Johnson)
    • 8.3.5.Exactech, Inc.
    • 8.3.6.Zimmer Biomet
    • 8.3.7.Arthrex, Inc.
    • 8.3.8.Medtronic
    • 8.3.9.Organogenesis Inc.
    • 8.3.10.Kuros Biosciences.

Chapter 9.Research Process

  • 9.1.Research Process
    • 9.1.1.Data Mining
    • 9.1.2.Analysis
    • 9.1.3.Market Estimation
    • 9.1.4.Validation
    • 9.1.5.Publishing
  • 9.2.Research Attributes
  • 9.3.Research Assumption